LIGAND PHARMACEUTICALS INCORPORATED Fair Value Adjustment of Warrants
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Fair Value Adjustment of Warrants of -$135.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2025-02-28
- LIGAND PHARMACEUTICALS INCORPORATED fair value adjustment of warrants for fiscal 2023 was -$135.00K.
| Period end | Fair Value Adjustment of Warrants 12 month |
|---|---|
| 2023-12-31 | -$135.00K 10-K · filed 2025-02-28 |